RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus

scientific article published on 01 May 1996

RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/AJCN/63.5.753
P698PubMed publication ID8615360

P50authorScott M. GrundyQ56230139
P2093author name stringA Garg
I Jialal
C J Fuller
M Chandalia
P433issue5
P304page(s)753-759
P577publication date1996-05-01
P1433published inAmerican Journal of Clinical NutritionQ7713500
P1476titleRRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus
P478volume63